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Purpose: The effects of partial nephrectomy (PN) on postoperative blood pressure (BP) 
are not known, and PN has the potential to worsen BP. We therefore sought to determine 
whether PN alters postoperative BP. 
Materials and Methods: Patients who underwent PN for suspected malignancy at our 
institution from 2002 to 2008 were included. Data on BP and medication from before 
and after PN were retrieved from family physicians. BP and number of anti-
hypertensive medications were compared after surgery with preoperative values by 
use of paired t tests and Chi-squared analyses, respectively. 
Results: Of 74 patients undergoing PN and providing consent, 48 met the inclusion and 
exclusion criteria, with a median follow-up of 24 months. For the early postoperative 
period (1 month to 1 year after surgery), the mean BPs (132.3/77.0 mmHg) were un-
changed compared with preoperative values (132.4/78.0 mmHg; p=0.59 systolic BP and 
p=0.30 diastolic BP). For the later postoperative period (beyond 1 year after surgery), 
the mean postoperative systolic BP was unchanged from the mean preoperative systolic 
BP (131.2 mmHg vs. 132.4 mmHg, respectively; p＞0.30). However, the corresponding 
average diastolic BP was lower in the long term (78.0 mmHg versus 76.4 mmHg re-
spectively; p=0.01). No significant difference in the mean number of BP medications 
prescribed preoperatively, at one year, and beyond one year was identified (p＞0.37). 
Conclusions: PN does not result in initial or long-term postoperative deterioration in 
BP. 
Key Words: Blood pressure; Hypertension, Kidney cancer; Kidney failure; Partial 
nephrectomy
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
Article History:
received 4 April, 2011
accepted 16 August, 2011
Corresponding Author:
Nathan Lawrentschuk
Ludwig Institute for Cancer Research, 
Department of Surgery, Austin 
Hospital, University of Melbourne 
Faculty of Medicine, 145 Studley Road, 
PO Box 5555, Heidelberg, Victoria, 
3084, Australia
TEL: +61-3-9496-5468
FAX: +61-3-9458-1650
E-mail: lawrentschuk@gmail.com
INTRODUCTION
The management of small renal masses (up to 7 cm) has 
undergone a paradigm shift in the past 10 years from radi-
cal nephrectomy to renal sparing in the form of partial 
nephrectomy (PN), ablative interventions, and surveil-
lance [1]. Several series have shown similar disease-speci-
fic survival and recurrence rates for PN compared with rad-
ical nephrectomy for renal masses smaller than 4 to 7 cm 
with the preservation of renal function [2-4]. Patients un-
dergoing radical nephrectomy for renal masses tend to 
have a higher incidence of chronic renal insufficiency, car-
diovascular events, and proteinuria than do patients un-
dergoing PN [3,5-8].
Despite the advantage of preserving renal mass, the 
pathophysiological implications of PN are just beginning 
to be understood. PN has the potential to elicit a re-
nin-angiotensin response in the treated kidney and thus 
hypertension. Hypothetically, renal artery injury from hi-
lar clamping or the compressive effects of bolsters on the 
parenchymal defect after mass removal could mimic the 
Goldblatt one-clip two-kidney model of hypertension 
[9,10]. In short, reduced blood flow and glomerular capil-
lary pressure in the affected kidney could cause renin re-
lease and ensuing hypertension. A handful of case reports 
have indicated that PN may precipitate postoperative hy-Korean J Urol 2012;53:154-158
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pertension in the short term [11-13]. One older small series 
of 14 patients showed no long-term deterioration of blood 
pressure (BP) after PN in patients with a solitary kidney, 
although that study did not include comparison of post-
operative BP with preoperative BP [14]. The renal trauma 
literature suggests that renal injury can lead to post-
operative hypertension in the form of renal vascular in-
juries or the often mentioned “Page kidney” after renal re-
pair [15-17]. The donor transplant nephrectomy literature 
has conflicting studies with respect to the loss of renal mass 
on BP, with some showing a high incidence of hypertension 
after surgery [18,19] and one older study showing a mini-
mal effect on long-term BP [20]. The importance of hyper-
tension with respect to renal preservation is highlighted 
by a recent study identifying it as an independent risk fac-
tor for renal loss in radical and partial nephrectomies [7]. 
Therefore, the effect of PN for renal masses on post-
operative BP is important for clinical follow-up and is not 
well defined.
The hypothesis suggesting that PN can induce a post-
operative hypertensive response as a consequence of re-
nin-angiotensin activation appears plausible. Therefore, 
our aim was to initiate an exploratory study to describe the 
effect of PN on short- and long-term postoperative BP.
MATERIALS AND METHODS
1. Patient recruitment and data collection
A single-center, ethics-approved retrospective review of all 
PNs performed over 6 years (2002 to 2008) was conducted 
at the Queen Elizabeth II Health Sciences Center, Depart-
ment of Urology in Halifax, Nova Scotia, Canada. The 
6-year cut-off was selected because before this time period, 
PN was not a common procedure. Consent forms and ex-
planatory cover letters were mailed to all 112 consecutive 
patients originally identified, and 74 provided informed 
consent. Of the 74 family physician offices contacted, 62 re-
leased information on BP and medications. Other patient 
information was also obtained from electronic and paper 
health records. 
The inclusion criteria were patients ≥18 years of age, 
who underwent PN for presumed renal cell carcinoma, and 
who were followed by a family physician and had at least 
two BP readings taken during the 2 years before surgery 
and at least two BP measurements taken ＞1 month after 
surgery. The initial postoperative period was excluded to 
avoid effects of postoperative pain and anxiety on BP. 
Preoperative BP data were generated before patients were 
diagnosed with a renal cancer, thereby excluding anxi-
ety-induced BP alterations. We excluded patients if con-
sent was not given for information release or if insufficient 
BP information was available (less than two readings be-
fore or after surgery). Patients on dialysis within 2 years 
of surgery were excluded, thus eliminating the complexity 
of dialysis-related BP variability. Patients pregnant with-
in 2 years before or after surgery were excluded. Patients 
with metastatic renal cancer within 2 years before or after 
surgery were excluded, because associated pain, anxiety, 
and paraneoplastic syndromes could complicate results. 
Patients with chronic renal failure (creatinine clearance 
＜20 ml/h) and patients with greater than one renal sur-
gery were also excluded. Of 62 patients available before ex-
clusions, 10 had insufficient BP information, 2 developed 
early metastatic disease, 1 developed kidney failure, and 
1 had bilateral kidney surgeries. 
2. Study endpoints
The main study variables assessed were mean systolic BP 
(SBP) and diastolic BP (DBP). The mean SBPs and DBPs 
were calculated separately before and after surgery. 
Unfortunately, owing to the retrospective nature of this 
study, we could not control for the temporal variability of 
BP readings before and after surgery. Therefore, BPs taken 
during the 2-year period before surgery were averaged, 
whereas the mean of BPs taken after surgery was stratified 
by the early postoperative period (1-12 months) and the late 
postoperative period (12 months to the end of follow-up). 
The secondary endpoint assessed was the mean number of 
BP medications used before (at the last family physician 
office visit before surgery) and after surgery. Postoperative 
BP medication tallies were also subdivided into the early 
and delayed postoperative period as above, with the num-
ber of medications at the last family physician visit closest 
to 1 year postoperatively and those at the last follow-up in-
corporated into our analysis. The number of patients tak-
ing angiotensin-converting enzyme inhibitors (ACEI) or 
angiotensin receptor blockers (ARB) was compared in-
dependent of other medications.
3. Statistical analysis 
Differences between mean SBPs and DBPs before and after 
surgery were analyzed with a paired t test. A p-value of 
＜0.05 was considered statistically significant. Medication 
comparisons from before and after surgery were analyzed 
by using a chi-squared test. Statistical analysis was per-
formed with GraphPad Prism ver. 4.01 (GraphPad Soft-
ware Inc., La Jolla, CA, USA).
RESULTS
The characteristics of the patient cohort are summarized 
in Table 1. The overall mean preoperative SBP/DBP was 
132.4/78.0 mmHg and when compared with the overall 
postoperative BP (132.2/76.7 mmHg) was not significantly 
different (p=0.87 for systolic and p=0.16 for diastolic). 
Table 2 shows the comparison of preoperative BP with BP 
in the early postoperative period (1 month-1 year) and the 
late postoperative period (＞1 year). No significant differ-
ence was found in diastolic or systolic BP when pre-
operative measurements were compared with measure-
ments in the early postoperative period (p≥0.3). Assess-
ment of late postsurgery BP (＞12 months after surgery) 
identified no significant difference in mean SBP compared 
with before surgery, with a median follow-up time of 24 Korean J Urol 2012;53:154-158
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TABLE 1. Patient cohort characteristics
Variable Value
Number of patients analyzed, N (%)
Total
Female
Male
Median age in years (range)
Post-op follow-up
Median in months (range)
Mean in months
Preop comorbidities, N (%)
HTN
DM
Cardiac
Solitary kidney, N (%)
Median tumor size in cm (range)
Tumor histology, N (%)
Clear cell
Papillary
Angiomyolipoma
Oncocytoma
Hemangiopericytoma
Non-cancer renal histopathologies, N (%)
Nephrosclerosis 
Arteriosclerosis
Chronic interstitial inflammation
Diabetic nephropathy
Tumor side, N (%)
Left
Right
Surgical approach, N (%)
Open
Laparoscopic
Median ischemia time in min (range)
Cold n=3
Warm open n=14
Warm lap n=26
No data
Median Fuhrman grade (range)
AJCC pathologic tumor stage 23, N (%)
pT1a
pT1b
pT2a
Benign
Serum creatinine (mmol/l)
Mean±SD Pre-op 
Mean±SD Post-op
Mean number BP measurements (IQR)
Preop
Postop
  48 (100)
17 (35)
31 (65)
     63 (28-78)
   24 (2-72)
27.8
33 (69)
10 (21)
13 (27)
2 (4)
   3.2 (0.6-7)
27 (56)
17 (35)
2 (4)
1 (2)
1 (2)
29 (60)
  5 (10)
2 (4)
1 (2)
25 (52)
23 (48)
20 (42) 
28 (58)
  31.5 (28-36)
 21.1 (2-33)
a
   28.8 (15-58)
a
2 lap; 3 open
   2 (1-4)
34 (71)
  6 (13)
3 (6)
  5 (10)
91.3±27.0
b
93.2±31.2
b
6.1 (3-9)
4.7 (2-6)
Values are presented as number (%) or median (range).
HTN, hypertension; DM, diabetes mellitus; lap, laparoscopic; 
AJCC, American Joint Committee on Cancer; SD, standard devi-
ation; BP, blood pressure; IQR, interquartile range.
a: Comparison of open and lap warm ischemia time, p=0.037. 
b: 
AJCC Cancer Staging Manual, 7th ed., Reference [23], 
c: 
Comparison of preoperative to postoperative creatinine, p=0.43.
months (p=0.34). However, the corresponding mean DBP 
was significantly lower in the delayed group (76.4 mmHg 
vs. 78.0 mmHg), with an absolute difference of 1.6 mmHg 
(p=0.01). The cohort was also stratified by the laparoscopic 
and open approach with no significant difference in post-
operative BP noted in either group relative to preoperative 
BP (data not shown). 
As depicted in Fig. 1, there was no significant difference 
between the mean number of BP medications prescribed 
preoperatively (1.2), at 12 months (1.4, p=0.38), and beyond 
12 months (1.3, p=0.44). Furthermore, the number of pa-
tients prescribed ACEI and ARB anti-hypertensives did 
not differ significantly from preoperative to any post-
operative time points (p=0.58), with a total of 3/32 patients 
undergoing a dosage increase in either of these medica-
tions.
DISCUSSION
This is the first series to determine the effects of PN on pre-
operative versus postoperative BP. With the use of BP 
measurements routinely performed by family physicians, 
we retrospectively compared preoperative and post-
operative BPs in 48 patients with a follow-up of 2 years. In 
the total cohort, there was no significant change in mean 
SBP or DBP within 1 year after surgery. Beyond 1 year after 
surgery, a minor improvement in DBP (1.6 mmHg) occu-
rred with no change in SBP. The improvement in DBP was 
probably not clinically significant. Therefore, BP in the 
short-term and long-term appears to be preserved after 
PN, although the possibility remains for an increase or de-
crease in BP in a cohort with a longer follow-up or more pa-
tients recruited. These findings reject the hypotheses sug-
gesting that the technique of PN can induce a postoperative 
hypertensive response as a consequence of renin-angio-
tensin activation. 
An alternative explanation is that renal masses them-
selves could cause compressive effects on surrounding re-
nal parenchyma or generate paraneoplastic syndromes 
that result in hypertension. A recent study from Montene-
gro showed an improvement in hypertension in 24 patients 
undergoing radical nephrectomy for renal cell carcinoma 
[21]. The average preoperative BP in that study was partic-
ularly high (161/99 mmHg) compared with our study 
(132/78 mmHg), and no details on tumor size or methods 
of recording BP were provided. Given that all patients in 
the Montenegro study underwent a radical nephrectomy, 
it is likely that the patient population in that study had 
much larger tumors than did our cohort, which could have 
a stronger negative influence on BP through paraneo-
plastic or compressive effects on the renal parenchyma. A 
major strength of our study is that preoperative BP data 
were generated before the patients were diagnosed with a 
renal cancer to reduce any anxiety or stress-related impact 
on BP, which was not likely the case in the study from 
Montenegro.
Several transplant nephrectomy studies are contra-Korean J Urol 2012;53:154-158
Effects of Partial Nephrectomy on Postoperative Blood Pressure 157
TABLE 2. Paired comparison of blood pressure measurements from before and different time ranges after surgery
BP measurement Pre-op
Post-op follow-up
＜1 yr
p-value vs. 
pre-op
＞1 yr
p-value vs. 
pre-op
Systolic in mmHg:
    Mean (SD)
    Median (IQR)
Diastolic in mmHg:
    Mean (SD)
    Median (IQR)
132.4 (11.69)
132.1 (123.7-140.2)
78.0 (5.58)
77.5 (74.5-81.5)
132.3 (12.19)
130.8 (123.0-139.3)
77.0 (6.16)
76.9 (73.8-80.0)
0.59
0.30
131.2 (11.23)
131.0 (123.3-136.5)
76.4 (6.45)
77.0 (71.2-80.3)
0.34
0.01
SD, standard deviation; IQR, interquartile range. 
FIG. 1. Mean number of medications taken per patient before 
surgery compared with at 1 year after surgery and beyond 1 year 
at the last follow-up (p＞0.37).
dictory to the Montenegro study and actually show an in-
crease in BP after nephrectomy [18,19]. The donor neph-
rectomy patient population is different in that these pa-
tients are highly selected, are younger in age, have minimal 
baseline comorbidities, and lack the potential paraneo-
plastic or compressive effects of renal tumors. With respect 
to our study, the possibility remains that postsurgery BP 
elevation could be masked by preoperative hypertension 
caused by the renal mass (compressive effects or paraneo-
plastic syndrome). Indeed, one cause of hypertension (the 
renal mass) could have been replaced by another cause of 
hypertension (surgical factors stimulating angiotensin), 
thus balancing out the effect of PN on BP. Alternatively, 
hypertension may have been caused by the tumor, whereby 
removing the tumor improved the BP as noted by the im-
provement in DBP in the total cohort beyond 1 year and the 
trend toward improvement in SBP and DBP in those under-
going an open approach. However, the prevalence of pre-
operative hypertension in our study population (69%) was 
similar to the published Canadian prevalence of hyper-
tension in this age group (66%) [22], which suggests that 
there was minimal if any effect of renal masses on the in-
cidence of preoperative hypertension. 
One drawback in our study design is a potential bias for 
selecting patients who are closely followed with BP meas-
urements by family physicians. These patients may have 
tighter BP control with medications, which could lead to a 
false-negative effect on BP. We addressed this concern by 
tabulating the number of BP medications the patients were 
taking before and after surgery. There were no significant 
differences in the number of BP medications taken before 
and after surgery. We were only able to reliably track ACEI 
and ARB medication dosage changes and found no sig-
nificant dosage changes, which suggests a low likelihood 
of significant dosage changes to other antihypertensives. 
Therefore, medication adjustments had a low chance of af-
fecting our results. Unfortunately, owing to the retro-
spective nature of our study, we were unable to account for 
changes in medications other than antihypertensives that 
could also affect blood pressure.
Another limitation in our study was the lack of a control 
comparison group such as patients who underwent radical 
nephrectomy. However, because we compared patients in 
a pairwise fashion (preoperative to postoperative) and 
demonstrated no effect on BP, a control group would not 
have changed our conclusion with respect to our original 
hypothesis. In addition, the majority of patients who un-
dergo PN in our institution have masses ＜4 cm, such that 
a radical nephrectomy cohort would not be an equivalent 
control group because these patients typically have much 
larger renal masses with more potential to impact BP. 
Another limitation of our study was the lack of control of 
BP measurements with respect to setting, time of day, and 
technique. However, by using a paired design such that the 
same family physician performed the measurement before 
and after surgery, we tried to minimize inter-observer 
variability. 
CONCLUSIONS
This study, although exploratory, provides the first evi-
dence that PN for small renal masses in a contemporary 
cohort is not likely a risk factor for worse BP outcome com-
pared with before surgery. The lack of BP deterioration is 
particularly important in view of the recent evidence iden-
tifying hypertension as an independent risk factor for renal 
impairment after partial or radical nephrectomy [7]. Korean J Urol 2012;53:154-158
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Overall, these results should be generalizable with respect 
to the effect of PN on BP in the cohort of patients with renal 
masses less than 4 cm. A larger follow-up study is required 
to confirm these results. 
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